Cite
Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin.
MLA
Ballard, Jeffrey L., et al. “Safety and Immunogenicity Observations Pooled from Eight Clinical Trials of Recombinant Human Thrombin.” Journal of the American College of Surgeons, vol. 210, no. 2, Feb. 2010, pp. 199–204. EBSCOhost, https://doi.org/10.1016/j.jamcollsurg.2009.09.042.
APA
Ballard, J. L., Weaver, F. A., Singla, N. K., Chapman, W. C., & Alexander, W. A. (2010). Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin. Journal of the American College of Surgeons, 210(2), 199–204. https://doi.org/10.1016/j.jamcollsurg.2009.09.042
Chicago
Ballard, Jeffrey L, Fred A Weaver, Neil K Singla, William C Chapman, and W Allan Alexander. 2010. “Safety and Immunogenicity Observations Pooled from Eight Clinical Trials of Recombinant Human Thrombin.” Journal of the American College of Surgeons 210 (2): 199–204. doi:10.1016/j.jamcollsurg.2009.09.042.